PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25662586-1	2015	The peroxisome proliferator-activated receptor (PPAR)-beta/delta has emerged as a promising therapeutic target for treating dyslipidemia, including beneficial effects on HDL cholesterol (HDL-C).	Cholesterol	174-185	peroxisome proliferator activator receptor delta	Mus musculus	4-58	
25662586-9	2015	Our results also indicate that PPAR-beta/delta activation may modulate PLTP-mediated prebeta-HDL formation and macrophage cholesterol efflux.	Cholesterol	122-133	peroxisome proliferator activator receptor delta	Mus musculus	31-40